Kirby John J.
- SEC CIK
- 0001556327
In the past year, 2 open-market purchase filings worth $39.6K and no sales.
Current role at each company
- VRCA Verrica Pharmaceuticals Inc.Interim CFOas of Aug 18, 2026
- ACGN Aceragen, Inc.CHIEF FINANCIAL OFFICERas of Feb 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $39.6K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$39.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kirby John J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRCA Verrica Pharmaceuticals Inc.
Interim CFO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Kirby John J.Interim CFO | PPurchase | +3.54K | $4.24 | +$15.0K | +65.2%8.96K after | |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Kirby John J.Interim CFO | PPurchase | +884 | – | – | –884 after | Derivative |
| Aug 18, 2026 (view filing)5:00 PM ET | Aug 18 | Same day | Kirby John J.Interim CFO | PPurchase | +5.00K | $4.93 | +$24.6K | +26.4%24.0K after |
ACGN Aceragen, Inc.
CHIEF FINANCIAL OFFICER1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Kirby John J.CHIEF FINANCIAL OFFICER | PPurchase | +10.0K | $0.62 | +$6.20K | +36.2%37.6K after |